Trials / Suspended
SuspendedNCT00787293
Study of Safety and Efficacy of the Percutaneous Reduction of Mitral Valve Regurgitation in Heart Failure Patients
A Multi-center Study of the Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty System to Reduce Mitral Valve Regurgitation in Patients With Heart Failure
- Status
- Suspended
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Viacor · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
Improvement in heart failure with moderate to severe mitral regurgitation using a percutaneously delivered implantable device.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | PTMA (Percutaneous Transvenous Mitral Annuloplasty) Implant | Percutaneous assessment from right or left subclavian vein, with PTMA implant in the coronary sinus, great cardiac vein, anterior interventricular vein. |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2010-11-01
- Completion
- 2015-11-01
- First posted
- 2008-11-07
- Last updated
- 2011-02-14
Locations
13 sites across 5 countries: Belgium, Czechia, Germany, Netherlands, Switzerland
Source: ClinicalTrials.gov record NCT00787293. Inclusion in this directory is not an endorsement.